New study suggests it costs $1.3B in R&D investment to bring a drug to market. How did it get there?
Politicians, pundits and patient groups now have a new number at their disposal when drugmakers cite high R&D costs — as much as $2.8 billion in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
